No image published for this recall
Teva Pharmaceuticals Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30 - safety alert
Official notice
15 Aug 2012
Last checked
15 Aug 2012
An official FDA notice concerns Teva Pharmaceuticals Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30 - safety alert. An official FDA notice concerns Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30. The notice reports a product safety risk. Follow the official notice for consumer instructions. Published 2012-08-15. Lots: X05011. Recall numbers: D-1442-2012. Check the official notice for the complete list. Published 2012-08-15.
What to do now
The source does not provide specific consumer instructions. Follow the official FDA notice for next steps.
Units affected
6,647
Recall number
D-1442-2012
Official notice
2012-08-15
The hazard
The hazard
An official FDA notice concerns Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30. The notice reports a product safety risk. Follow the official notice for consumer instructions. Published 2012-08-15. Lots: X05011. Recall numbers: D-1442-2012. Check the official notice for the complete list.
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Follow the official notice if they match.
Lots
Event Ids
Recall Numbers
Checked manually this time?
The app alerts you when a new official recall is published — no searching, no checking back.
Turn on recall alertsAffected products
Affected products
Product 1
Units affected
Risk / hazard
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected products were sold.
Location 1
Affected area 1
Affected area 2
Company & contacts
Company & contacts
Brand: Teva Pharmaceuticals. Contact: Teva Pharmaceuticals USA, Inc..
Source & status
Source & status
Recall details
Recall details
Recall number
Event id
Units affected
Status
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeRelated recalls
a product listed in the official notice - safety alert
2 Jul 2025a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
Weekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 15 Aug 2012. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
